Bader M
Max-Delbrück-Center for Molecular Medicine (MDC), Berlin-Buch, Germany.
Braz J Med Biol Res. 1998 Sep;31(9):1171-83. doi: 10.1590/s0100-879x1998000900011.
The interplay of vasoactive peptide systems is an essential determinant of blood pressure regulation in mammals. While the endothelin and the renin-angiotensin systems raise blood pressure by inducing vasoconstriction and sodium retention, the kallikrein-kinin and the natriuretic-peptide systems reduce arterial pressure by eliciting vasodilatation and natriuresis. Transgenic technology has proven to be very useful for the functional analysis of vasoactive peptide systems. As an outstanding example, transgenic rats overexpressing the mouse Ren-2 renin gene in several tissues become extremely hypertensive. Several other transgenic rat and mouse strains with genetic modifications of components of the renin-angiotensin system have been developed in the past decade. Moreover, in recent years gene-targeting technology was employed to produce mouse strains lacking these proteins. The established animal models as well as the main insights gained by their analysis are summarized in this review.
血管活性肽系统之间的相互作用是哺乳动物血压调节的一个重要决定因素。内皮素系统和肾素 - 血管紧张素系统通过诱导血管收缩和钠潴留来升高血压,而激肽释放酶 - 激肽系统和利钠肽系统则通过引起血管舒张和利钠作用来降低动脉血压。转基因技术已被证明对血管活性肽系统的功能分析非常有用。一个突出的例子是,在多个组织中过度表达小鼠Ren-2肾素基因的转基因大鼠会变得极度高血压。在过去十年中,还开发了其他几种对肾素 - 血管紧张素系统成分进行基因改造的转基因大鼠和小鼠品系。此外,近年来采用基因靶向技术培育出了缺乏这些蛋白质的小鼠品系。本综述总结了已建立的动物模型及其分析所获得的主要见解。